Intelligent Medicine Acquisition Accounts Payable

The latest accounts payable for IQMD is $470K as of December 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Intelligent Medicine Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, IQMD's accounts payable moved from $0 to $470K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intelligent Medicine Acquisition's operating scale or balance-sheet position.

A accounts payable figure of $470K for IQMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMD's accounts payable ($470K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.